Who Exports Praziquantel from India — 148 Suppliers Behind a $2.9M Market
India's praziquantel export market is supplied by 148 active exporters who collectively shipped $2.9M across 584 shipments. LOB INTERNATIONAL leads with a 25.4% market share, followed by MEDOPHARM PRIVATE LIMITED and BDH INDUSTRIES LIMITED. The top 5 suppliers together control 43.6% of total export value, reflecting a moderately competitive market structure.
Top Praziquantel Exporters from India — Ranked by Export Value
LOB INTERNATIONAL is the leading praziquantel exporter from India, holding a 25.4% share of the $2.9M market across 584 shipments from 148 exporters. The top 5 suppliers — LOB INTERNATIONAL, MEDOPHARM PRIVATE LIMITED, BDH INDUSTRIES LIMITED, MACLEODS PHARMACEUTICALS LTD, ASHISH LIFE SCIENCE PRIVATE LIMITED — collectively control 43.6% of total export value, indicating a competitive market. Individual shares are: LOB INTERNATIONAL (25.4%), MEDOPHARM PRIVATE LIMITED (6.0%), BDH INDUSTRIES LIMITED (4.7%), MACLEODS PHARMACEUTICALS LTD (4.0%), ASHISH LIFE SCIENCE PRIVATE LIMITED (3.5%).
Top Praziquantel Exporters from India
Ranked by export value · 148 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | LOB INTERNATIONAL PRAZIQUANTEL 600MG FILM COATED TABLETS PRAZEEPHARMACEUTICAL PRODUCTS PRAZIQUANTEL TAB | $743.2K | 1 | 25.4% |
| 2 | MEDOPHARM PRIVATE LIMITED PRAZIQUANTEL TABLETS USP 600MGPRAZIQUANTEL TABLETS USP 600 MG. TABLETSPRAZIQUANTEL PYRANTEL PAMOTE & FENBENDA | $174.6K | 1 | 6.0% |
| 3 | BDH INDUSTRIES LIMITED PRAZIQUANTEL TABLETS USP 600 MG. TABLETSPRAZIQUANTEL PYRANTEL PAMOTE & FENBENDAZEROKRIM CH(PRAZIQUANTEL,PYRANTEL PAMOAT | $138.2K | 2 | 4.7% |
| 4 | MACLEODS PHARMACEUTICALS LTD MEDICINES. PRAZIQUANTEL 600 MG TABLETS (PRAZIQUANTEL 600 MG TABLETS 10X10S 365PRAZIQUANTEL 600 MG TABLETS 10X10S (996 | $116.3K | 3 | 4.0% |
| 5 | ASHISH LIFE SCIENCE PRIVATE LIMITED PRAZIQUANTEL TABLETS USP 600 MG. TABLETSPHARMACEUTICALS DRUGS & MEDICINES PRAZISTAL - 600PRAZIQUANTEL PYRANTEL PAMOTE & FENBENDA | $101.9K | 11 | 3.5% |
| 6 | MEDOPHARM PRAZIQUANTEL TABLETS USP 600MGPRAZIQUANTEL TABLETS USP 600 MG. TABLETSPRAZIQUANTEL PYRANTEL PAMOTE & FENBENDA | $97.8K | 5 | 3.3% |
| 7 | BHARAT PARENTERALS LIMITED PHARMACEUTICALS DRUGS & MEDICINES PRAZISTAL - 600"PRAZISTAL-600 PRAZIQUANTEL TABLETS USP600MG "PRAZIQUANTEL TABLETS USP 600MG. UNIT PACK 1X30 TAB IN JAR. | $74.4K | 1 | 2.5% |
| 8 | AGIO PHARMACEUTICALS LIMITED | $72.5K | 2 | 2.5% |
| 9 | ZENEX ANIMAL HEALTH INDIA PRIVATE LIMITED ALFANIL PLUS 2S KENYA | $71.4K | 2 | 2.4% |
| 10 | CIARA PHARMACEUTICALS PHARMACEUTICALS DRUGS & MEDICINES PRAZISTAL - 600"PRAZISTAL-600 PRAZIQUANTEL TABLETS USP600MG "PRAZIQUANTEL TABLETS USP 600MG. UNIT PACK 1X30 TAB IN JAR. | $59.1K | 1 | 2.0% |
| 11 | MACLEODS PHARMACEUTICALS LIMITED MEDICINES. PRAZIQUANTEL 600 MG TABLETS (PRAZIQUANTEL 600 MG TABLETS 10X10S 365PRAZIQUANTEL 600 MG TABLETS 10X10S (996 | $53.5K | 1 | 1.8% |
| 12 | UMEDICA LABORATORIES PRIVATE LIMITED PHARMACEUTICALS DRUGS & MEDICINES PRAZISTAL - 600"PRAZISTAL-600 PRAZIQUANTEL TABLETS USP600MG "PRAZIQUANTEL TABLETS USP 600MG. UNIT PACK 1X30 TAB IN JAR. | $50.1K | 2 | 1.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Praziquantel exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Medopharm Private Limited | Not Listed | Yes, as of January 2 | Yes | Not verified | WHO-GMP certified in January 2025; EU GMP compliant as of June 2024. (extranet.w |
| Macleods Pharmaceuticals Limited | Not Listed | Yes, as of April 202 | Yes | Not verified | WHO-GMP certified in April 2024; EU GMP compliant as of October 2022. (extranet. |
| Umedica Laboratories Private Limited | Approved | Yes | Yes | Not verified | FDA approved; WHO-GMP and EU GMP compliant. |
TransData Nexus reviewed the regulatory standing of 3 leading Praziquantel exporters from India. 1 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 3 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Praziquantel sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts Genome Valley, India's first biotech cluster, and is home to over 800 pharmaceutical companies, including industry leaders such as Dr. Reddy’s Laboratories and Aurobindo Pharma. This concentration of expertise and infrastructure makes Hyderabad a significant center for the manufacturing of APIs like Praziquantel.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production and houses major companies such as Zydus Cadila and Torrent Pharmaceuticals. This region's robust infrastructure and regulatory compliance make it a key area for the production of finished pharmaceutical products, including Praziquantel tablets.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a crucial export gateway for pharmaceuticals. With its proximity to major ports and a well-established industrial base, this region facilitates the export of pharmaceutical products to global markets. Companies in this area are instrumental in distributing medications like Praziquantel to various countries, leveraging the region's logistical advantages.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi and Nalagarh in Himachal Pradesh form one of Asia's largest pharmaceutical hubs, benefiting from favorable tax incentives and a supportive industrial policy. This region hosts numerous pharmaceutical manufacturing units, contributing significantly to India's pharmaceutical output. The presence of these facilities enhances the availability and production capacity for drugs such as Praziquantel.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Assess Regulatory Compliance: Ensure that suppliers adhere to international quality standards and possess necessary certifications for exporting Praziquantel.
- Evaluate Logistics Infrastructure: Consider the logistical capabilities of each region, especially proximity to ports and transportation networks, to optimize supply chain efficiency.
- Monitor Market Dynamics: Stay informed about regional policies, tax incentives, and industrial developments that may impact production costs and supplier reliability.
By strategically sourcing from these diverse pharmaceutical clusters, companies can enhance the resilience and efficiency of their supply chains for Praziquantel.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Praziquantel exporters from India
Macleods Pharmaceuticals Ltd — Macleods Pharmaceuticals expands manufacturing capacity in Gujarat
In June 2025, Macleods Pharmaceuticals Ltd announced the expansion of its manufacturing facility in Gujarat, India, to increase production capacity for various pharmaceutical products. This expansion aligns with the company's strategy to meet growing global demand. - IMPACT: The increased production capacity is expected to enhance Macleods Pharmaceuticals' ability to fulfill international orders, potentially boosting Praziquantel exports.
Impact: The increased production capacity is expected to enhance Macleods Pharmaceuticals' ability to fulfill international orders, potentially boosting Praziquantel exports.
Common Questions — Praziquantel Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which praziquantel supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, LOB INTERNATIONAL leads with 8 recorded shipments worth $743.2K. MEDOPHARM PRIVATE LIMITED (4 shipments) and BDH INDUSTRIES LIMITED (7 shipments) are also established high-volume exporters.
Q How many praziquantel manufacturers are there in India?
India has 148 active praziquantel exporters with a combined export market of $2.9M across 584 shipments to 80 countries. The top 5 suppliers hold 43.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for praziquantel from India?
Average FOB unit price: $8.26 per unit, ranging from $0.00 to $814.00. Average shipment value: $5.0K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 148 verified Indian exporters of Praziquantel ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 584 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 80 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
584 Verified Shipments
148 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists